Ownership history in Hudock, Inc. Β· 53 quarters on record
This page tracks every 13F SEC filing in which Hudock, Inc. reported a position in VWO MSCI EMR MKT ETF (VWO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Hudock, Inc. underperformed the S&P 500 by β9.3% annually on this VWO position. Timing score: 50% (26/52 decisions correct). Average cost basis: $32.51. Maximum drawdown during holding period: β29.9%.
β Significantly underperformed the S&P 500 by 9.3% ann.
52 quarters analyzed
β‘οΈ Neutral timing β roughly coin-flip accuracy on add/trim calls.
26 of 52 add/trim decisions correct
Best entry: $24.39 (2015 Q4) Β· Worst: $53.76 (2025 Q4)
πͺ Held through 3 major drawdowns (>20%). Diamond-hands conviction.
41 adds Β· 12 trims. Bought during 18 of 20 down-price quarters. π Consistently bullish β fund kept accumulating this position.
π Hudock, Inc. has been actively increasing its VWO allocation β a bullish signal from insiders.
Currently 4.77% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size